The study by Gloyn et al., published in 2003, included 854 patients with T2D and 1182 controls and reported an 18% increase in the risk of T2D in the carriers of Glu23Lys of KCNJ11 [21]. This evidence concerns the gene KCNJ11 and type 2 diabetes mellitus.